MALLORY VANDEVENDER: Open Payments
NPI 1578218616 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,849 in 185 payments from 23 companies in 2025. Trend: 2023 $2,484 · 2024 $2,134 · 2025 $2,849
Food & beverage: $2,849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $511 |
| AstraZeneca Pharmaceuticals LP | 20 | $427 |
| Novo Nordisk Inc | 22 | $285 |
| Corcept Therapeutics | 16 | $239 |
| PFIZER INC. | 11 | $186 |
| GlaxoSmithKline, LLC. | 10 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $167 |
| Lilly USA, LLC | 14 | $159 |
| Lundbeck LLC | 6 | $123 |
| Phathom Pharmaceuticals, Inc. | 6 | $95 |
Products named: Korlym, UBRELVY, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, CAPLYTA, REXULTI, VRAYLAR.
Industry payments across MS — which companies pay providers there.
